Advertisement

Purpose:

Findings are inconsistent in a few studies of the effect of n-3 fatty acid supplementation on urinary calcium and oxalate excretion in stone formers. We evaluated the physiological effects of supplementation with eicosapentaenoic acid and docosahexaenoic acid on urinary risk factors for calcium oxalate stone formation under standardized conditions.

Materials and Methods:

We studied 15 healthy subjects initially while consuming a standardized diet for 5 days (control phase). During consecutive intervention phases 1—5-day standardized diet, 2—20-day free diet and 3—5-day standardized diet participants received 900 mg eicosapentaenoic acid and 600 mg docosahexaenoic acid daily. While ingesting the standardized diets, daily 24-hour urine samples were collected.

Results:

After short-term supplementation with eicosapentaenoic acid and docosahexaenoic acid in phase 1 we noted no changes in urinary parameters compared to the control phase. After 30-day supplementation with eicosapentaenoic acid and docosahexaenoic acid in phase 3 relative supersaturation with calcium oxalate decreased significantly by 23% from a mean ± SD of 2.01 ± 1.26 to 1.55 ± 0.84 due to significantly decreased urinary oxalate excretion (p = 0.023). Other urinary variables were not affected by supplementation.

Conclusions:

Results show that 30-day n-3 fatty acid supplementation effectively decreases urinary oxalate excretion and the risk of calcium oxalate crystallization. The mechanism of the physiological effect may be decreased cellular oxalic acid exchange attributable to an altered fatty acid pattern of membrane phospholipids with concomitant changes in oxalate transporter activity. Calcium oxalate stone formers may benefit from long-term n-3 fatty acid supplementation.

References

  • 1 : Current aspects of epidemiology and nutrition in urinary stone disease. World J Urol1997; 15: 165. Google Scholar
  • 2 : Polyunsaturated fatty acids in the food chain in the United States. Am J Clin Nutr2000; 71: 179S. Google Scholar
  • 3 : Dietary fats and membrane function: implications for metabolism and disease. Biol Rev2005; 80: 155. Google Scholar
  • 4 : Anomalous phospholipid n-6 polyunsaturated fatty acid composition in idiopathic calcium nephrolithiasis. J Am Soc Nephrol1996; 7: 613. Google Scholar
  • 5 : Eicosanoids in renal function. Prostaglandins Leukot Essent Fatty Acids1989; 36: 203. Google Scholar
  • 6 : Polyunsaturated fatty acids, inflammation and immunity. Eur J Clin Nutr2002; 56: S14. Google Scholar
  • 7 : The influence of renal prostaglandins on urinary calcium excretion in idiopathic urolithiasis. J Urol1983; 129: 421. LinkGoogle Scholar
  • 8 : The possible role of prostaglandin E2 in urinary stone formation. J Urol1988; 139: 549. LinkGoogle Scholar
  • 9 : Increased urinary excretion of prostaglandin E in patients with idiopathic hypercalciuria. Clin Sci1988; 75: 581. Google Scholar
  • 10 : Plasma phospholipid arachidonic acid content and calcium metabolism in idiopathic calcium nephrolithiasis. Kidney Int2000; 58: 1278. Google Scholar
  • 11 : Lipids as modulators of bone remodelling. Curr Opin Clin Nutr Metab Care2001; 4: 105. Google Scholar
  • 12 : Specific modulatory effect of arachidonic acid on human red blood cell oxalate transport: Clinical implications in calcium oxalate nephrolithiasis. J Am Soc Nephrol1999; 10: S381. Google Scholar
  • 13 : Incorporation and clearance of omega-3 fatty acids in erythrocyte membranes and plasma phospholipids. Clin Chem2006; 52: 2265. Google Scholar
  • 14 : The protective role of eicosapentaenoic acid (EPA) in the pathogenesis of nephrolithiasis. J Urol1991; 146: 188. LinkGoogle Scholar
  • 15 : Does fish oil benefit stone formers?. J Urol1993; 150: 1391. LinkGoogle Scholar
  • 16 : Effect of ethyl icosapentate on urinary calcium and oxalate excretion. Int J Urol2000; 7: 361. Google Scholar
  • 17 : Association of dietary fatty acids with urinary oxalate excretion in calcium oxalate stone-formers in their fourth decade. BJU Int2002; 89: 842. Google Scholar
  • 18 : Fatty acid intake and incident nephrolithiasis. Am J Kidney Dis2005; 45: 267. Google Scholar
  • 19 : An improved HPLC-enzyme-reactor method for the determination of oxalic acid in complex matrices. Clin Chim Acta1997; 261: 131. Google Scholar
  • 20 : Influence of a mineral water rich in calcium, magnesium and bicarbonate on urine composition and the risk of calcium oxalate crystallization. Eur J Clin Nutr2004; 58: 270. Google Scholar
  • 21 : EQUIL2: A basic computer program for the calculation of urinary saturation. J Urol1985; 134: 1242. LinkGoogle Scholar
  • 22 : Determination of seven prostanoids in 1 ml of urine by gas chromatography-negative ion chemical ionization triple stage quadrupole mass spectrometry. J Chromatogr1994; 652: 221. Google Scholar
  • 23 Referenzwerte für die Nährstoffzufuhr. In: Deutsche Gesellschaft für Ernährung, Österreichische Gesellschaft für Ernährung, Schweizerische Gesellschaft für Ernährungsforschung und Schweizerische Vereinigung für Ernährung. Frankfurt: Umschau Braus2000. Google Scholar
  • 24 : Abnormal arachidonic acid content of membrane phospholipids—the unifying hypothesis for the genesis of hypercalciuria and hyperoxaluria in idiopathic calcium nephrolithiasis. Nephrol Dial Transplant1999; 14: 553. Google Scholar
  • 25 : Effects of eicosapentaenoic acid on urinary calcium excretion in calcium stone formers. Eur Urol2001; 39: 580. Google Scholar
  • 26 : Evening primrose oil supplementation increases citraturia and decreases other urinary risk factors for calcium oxalate urolithiasis. J Urol2009; 182: 2957. LinkGoogle Scholar
  • 27 : Urinary prostaglandins: Identification and origin . J Clin Invest1975; 55: 763. Google Scholar
  • 28 : PGE1 compared to PGE2/PGF ratio as a marker for seminal fluid contamination of urine in studies of renal prostaglandin biosynthesis. Prostaglandins Leukot Essent Fatty Acids1991; 44: 47. Google Scholar
  • 29 : Eicosapentaenoic acid has a preventive effect on the recurrence of nephrolithiasis. Urol Int2008; 81: 135. Google Scholar
  • 30 : Urinary Stones: Diagnosis, Treatment, and Prevention of Recurrence. Basel: Karger2009. Google Scholar

Department of Urology, University of Bonn, Bonn and Department of Pediatrics, Philipps University Marburg (BW), Marburg, Germany

Advertisement